NCT04763577View on ClinicalTrials.gov

Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema

RecruitingOBSERVATIONAL

Enrollment

243

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

October 26, 2025

Study Completion Date

October 26, 2025

Conditions

Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor

Interventions

OTHER

Assay of Bradykinin-degradating enzymes.

Aminopeptidase P activity assay; Dipeptidyl peptidase IV activity assay; Angiotensin Converting Enzyme activity assay; MME gene polymorphisme exploration.

Trial Locations (4)

38043

RECRUITING

Chu Grenoble Alpes, Grenoble

59037

RECRUITING

CHRU de Lille _Hôpital Claude-Huriez, Lille

75571

RECRUITING

AP-HP _St Antoine, Paris

76 031

RECRUITING

CHU de Rouen, Rouen

All Listed Sponsors

collaborator

University Hospital, Paris

OTHER

collaborator

University Hospital, Rouen

OTHER

lead

University Hospital, Grenoble

OTHER

NCT04763577 - Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema | Biotech Hunter | Biotech Hunter